Optimizing the Diagnosis of Pneumocystis in Immunocompromised Patients
Recruiting
Observational Study
Pneumocystis
Immunocompromised Patients
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 240 (estimated)
- Sponsor
- Assistance Publique - Hôpitaux de Paris · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Evaluate new diagnostic methods using qPCR on non-invasive samples, compared with reference techniques for the positive diagnosis of pneumocystis (PcP) in immunocompromised patients
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* adult patients with suspected pneumocystis
* with an indication for bronchial fibroscopy for BAL or induced sputum
* no opposition to the research from the adult patient or his or her next of kin research for patients unable to express their non-opposition
Exclusion Criteria:…
Contacts